Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations. 1986

M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen

Antibody to the acquired immunodeficiency syndrome (AIDS) retrovirus was evaluated by an lymphadenopathy-associated (LAV) enzyme immunosorbent assay (EIA) and compared with the standard human T-cell lymphotropic virus, Type III (HTLV-III) screening test in two groups of people. The first group consisted of those at low risk for AIDS, including 1352 random volunteer donors, 1140 of whom were prospective donors and 212 of whom were retrospective donors, repeatedly reactive by HTLV-III EIA. The second group was composed of those at high risk for AIDS, including 54 hemophiliacs, one of whom had AIDS, seven AIDS-related complex (ARC), and one immune thrombocytopenia (ITP). Of the 1140 prospective donors, one was repeatedly reactive by LAV EIA and four by HTLV-III EIA; none was positive by Western blot. Of the 212 retrospective donors, six were repeatedly reactive by LAV EIA and 212 by HTLV-III EIA; only six (the six LAV EIA positive) were positive by Western blot. Of the 54 hemophiliacs, 46 were repeatedly reactive by both LAV EIA and HTLV-III EIA, and all 46 were positive by Western blot. Both LAV EIA and HTLV-III EIA were positive in all hemophiliacs with AIDS, ARC, and ITP. The marked reduction in HTLV-III EIA repeatedly reactive, Western blot nonreactive samples by the LAV EIA system suggests that this assay may be as sensitive but more specific than the standard HTLV-III EIA in low-risk populations. The strong correlation between the LAV EIA and the Western blot assay further suggests that this assay may provide an efficient screening test for AIDS antibody in the donor population.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D007163 Immunosorbent Techniques Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody. Immunoadsorbent Techniques,Immunoadsorbent Technics,Immunosorbent Technics,Immunoadsorbent Technic,Immunoadsorbent Technique,Immunosorbent Technic,Immunosorbent Technique,Technic, Immunoadsorbent,Technic, Immunosorbent,Technics, Immunoadsorbent,Technics, Immunosorbent,Technique, Immunoadsorbent,Technique, Immunosorbent,Techniques, Immunoadsorbent,Techniques, Immunosorbent
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D017977 Deltaretrovirus A genus in the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B- or adult T-cell leukemia/lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), and bovine leukemia (ENZOOTIC BOVINE LEUKOSIS). The type species is LEUKEMIA VIRUS, BOVINE. BLV-HTLV Viruses,HTLV Viruses,HTLV-BLV Viruses,Human T-Cell Leukemia Viruses,Human T-Cell Leukemia-Lymphoma Viruses,Leukemia Viruses, Human T-Cell,T-Cell Leukemia Viruses, Human,Human T Cell Leukemia Lymphoma Viruses,Human T Cell Leukemia Viruses,Leukemia Viruses, Human T Cell,T Cell Leukemia Viruses, Human,BLV HTLV Viruses,HTLV BLV Viruses

Related Publications

M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen
January 1985, Journal of immunological methods,
M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen
January 1986, Transfusion,
M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen
January 1986, Annual review of immunology,
M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen
January 1985, JAMA,
M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen
January 1986, AIDS research,
M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen
July 1985, Presse medicale (Paris, France : 1983),
M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen
January 1986, The New York journal of dentistry,
M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen
July 1984, MMWR. Morbidity and mortality weekly report,
M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen
May 1987, Journal of clinical microbiology,
M V Ragni, and J H Lewis, and M Bracken, and R Toth, and J Stokes, and D O Steffensen
January 1985, Pediatric infectious disease,
Copied contents to your clipboard!